期刊文献+

药品费用的影响因素分析——基于省级数据的实证研究 被引量:10

Analysis of Factors Affecting Drug Expenditure: an Empirical Study Based on the Provincial Data
下载PDF
导出
摘要 通过2000-2011年的省级面板数据,研究人均GDP、老龄化、医疗保险、教育水平、新药的引入、价格规制等因素对药品费用的影响。结果显示:人均GDP、老龄化、医疗保险对药品费用的上升有促进作用,对人均住院药品费用的影响要大于对人均门诊药品费用的影响;教育水平与药品费用的关系不明确;新药的引入会提升人均药品费用;药品价格规制对降低人均药品费用的作用很小。因此,单纯对药品价格的抑制未必能达到控制药品费用的目的,应采取合理的措施,挤出或控制药品费用增长的不合理部分。 By the provincial panel data from 2000 to 2011, this paper studies the effects of Per capita GDP, aging, medical insurance, education level, the introduction of new drugs, price regulation and other factors on drug expenditure, finds that per capita GDP, aging, medical insurance can promote the rise of drug expenditure, the effect on per capita hospitalization drug expenditure is greater than the effect on per capita outpatient drug expenditure, the relationship between education level and drug expenditure is not clear, the introduction of new drugs can rise per capita drug expenditure, and the drug price regulation has little effect on the reduction of the per capita drug expenditure. It is concluded that the inhibition of drug prices may not be able to achieve the purpose of controlling drug expenditure, the correct approach is to take reasonable measures to squeeze or control the unreasonable part of the increase in the expenditure of drugs.
作者 蒋建华
出处 《卫生经济研究》 北大核心 2015年第8期30-33,共4页
基金 广东省高等学校人文社科研究项目"我国药品价格规制效果研究"(2012WYXM_0017) 广东省卫生经济学会科学研究计划项目"我国药品价格规制效果不佳的原因与对策研究"的部分成果
关键词 药品费用 影响因素 价格规制 效果 drug expenditure influence factors price regulation effect
  • 相关文献

参考文献11

  • 1Chee Ruey Hsieh. Adoption of Pharmaceutical Innovation and the Growth of Drug Expenditure in Tai- wan: Is It Cost Effective? Valure in Health, 2007.
  • 2Frank R.G, Salkever D.S. Pricing, Patent loss and the market for Pharmaceuticals [J]. Southern Economic Journal, 1992, 59:165-179.
  • 3F. R. Lichtenberg. The Impact of New Drug Launches on Longevity: Evidence from Longitudinal Dis- eaevel Data from 52 Countries, 1982-2001. NBERWorking Paper,2003, 6:9754.
  • 4何志高.对当前我国遏制药品费用过快上涨政策的理性思考[J].中国药房,2005,16(18):1364-1366. 被引量:12
  • 5康永军,张洪彬,徐昌青.当前医疗费用上升的原因和对策[J].中华医院管理杂志,2005,21(4):220-223. 被引量:69
  • 6孙利华.遏制药品费用不合理增长的对策探讨[J].中国药房,2005,16(12):884-886. 被引量:16
  • 7Lopez-Casasnovas G, J. Puig-Junoy. Review of the literature on reference pricing [J]. Health Policy, 2000,54:87-123.
  • 8Rane, W. Price Control on Drugs Is Essential[J]. E- conomic and Political Weekly, 1998,33(42/43):2697-2698.
  • 9Brekke K.R, A.L. Grasdal,T.H. Holmas. Regu- lation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation [J].European Economic Review, 2009.53: 170-185.
  • 10Skinner, B.J. Canada's Drug Price Paradox: The Unexpected Losses Caused by Government Interference in Pharmaceutical Markets. Digital Publication(February). Vancouver: The Fraser Institute. Digital document avail- able athttp://www.fraserinstitute.org/commerce.web/prod- uct_files/CanadasDrugPricePar adox.pdf,2005.

二级参考文献18

共引文献93

同被引文献100

引证文献10

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部